Xaliproden fails in ALS, but hope remains
Benjamin Brooks
The experimental drug xaliproden has failed to fulfill the promise that earlier trials had hinted at, according to a report in the June issue of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders.
The drug was developed...